Stonebridge Capital Advisors LLC Biogen Inc. Transaction History

Stonebridge Capital Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$253.3 - $285.89 $7,345 - $8,290	-29 Reduced 32.58%	60 $15,000
Q2 2023 Aug 23, 2023	BUY	$275.25 - $318.06 $7,982 - $9,223	29 Added 48.33%	89 $25,000
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $2,565 - $2,923	-10 Reduced 14.29%	60 $16,000
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $387 - $488	-2 Reduced 2.78%	70 $15,000
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $2,687 - $3,453	-12 Reduced 14.29%	72 $17,000
Q2 2021 Aug 20, 2021	BUY	$259.0 - $414.71 $3,626 - $5,805	14 Added 20.0%	84 $29,000
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $17,006 - $19,924	70 New	70 $20,000
Q3 2020 Nov 18, 2020	SELL	$264.77 - $305.71 $2,647 - $3,057	-10 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$219.29 - $241.72 $2,192 - $2,417	10 New	10 $2,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Stonebridge Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Stonebridge Capital Advisors LLC with notifications on news.